SSKN - メラ・サイエンス (Strata Skin Sciences Inc.)

SSKNのニュース

   STRATA Skin Sciences (NASDAQ:SSKN) Downgraded to D at TheStreet  2021/12/13 06:08:42 ETF Daily News
TheStreet downgraded shares of STRATA Skin Sciences (NASDAQ:SSKN) from a c- rating to a d rating in a research note issued to investors on Thursday, TheStreetRatingsTable reports. Separately, Zacks Investment Research raised shares of STRATA Skin Sciences from a sell rating to a hold rating in a report on Wednesday, August 18th. Shares of SSKN [] The post STRATA Skin Sciences (NASDAQ:SSKN) Downgraded to D at TheStreet appeared first on ETF Daily News .
   STRATA Skin Sciences Announces Board of Directors Transition  2021/12/09 21:01:00 Intrado Digital Media
HORSHAM, Pa., Dec. 09, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that Douglas Strang was appointed to the Board of Directors, effective October 27, 2021. Mr. Strang will assume the role of Audit Committee Chair upon the departure of LuAnn Via, who will step down from the Board on December 31, 2021 as part of a planned transition.
   STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Update  2021/11/19 10:38:41 Dakota Financial News
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) was the target of a significant decline in short interest in October. As of October 29th, there was short interest totalling 19,800 shares, a decline of 33.3% from the October 14th total of 29,700 shares. Based on an average daily trading volume, of 70,200 shares, the days-to-cover ratio is presently []
   Renaissance Technologies LLC Sells 51,100 Shares of STRATA Skin Sciences, Inc. (NASDAQ:SSKN)  2021/11/15 11:24:43 Dakota Financial News
Renaissance Technologies LLC reduced its position in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) by 3.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,305,477 shares of the medical device company’s stock after selling 51,100 shares during the quarter. Renaissance Technologies LLC […]
   Renaissance Technologies LLC Has $2.04 Million Stake in STRATA Skin Sciences, Inc. (NASDAQ:SSKN)  2021/11/15 09:58:45 Dakota Financial News
Renaissance Technologies LLC decreased its holdings in STRATA Skin Sciences, Inc. (NASDAQ:SSKN) by 3.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,305,477 shares of the medical device companys stock after selling 51,100 shares during the quarter. Renaissance Technologies LLC owned 3.86% of []
   STRATA Skin Sciences to Present at Fall Harvest Best Ideas from the Buy-Side on Wednesday, October 6th, 2021  2021/09/29 12:00:00 Intrado Digital Media
HORSHAM, Pa., Sept. 29, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that the Company has been invited to present at the Fall Harvest Best Ideas from the Buy-Side conference. CEO, Robert J. Moccia will present at the conference.
   STRATA Skin Sciences to Participate in Upcoming Investor Conferences  2021/09/02 20:05:00 Intrado Digital Media
HORSHAM, Pa., Sept. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in two upcoming investor conferences.
   Ra Medical To Focus On Peripheral Artery Disease With Pharos Dermatology Divestiture  2021/08/17 09:16:50 Benzinga
Ra Medical Systems Inc (NYSE: RMED ) has sold its Pharos dermatology business to STRATA Skin Sciences Inc (NASDAQ: SSKN ) for $3.7 million in cash. The Pharos excimer laser is an FDA-cleared treatment for psoriasis, vitiligo, atopic dermatitis, and leukoderma. "We believe this transaction is in the best Full story available on Benzinga.com
   STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q2 2021 Results - Earnings Call Transcript  2021/08/17 01:44:08 Seeking Alpha
   Ra Medical Systems sells Pharos dermatology business to STRATA Skin Sciences  2021/08/16 20:26:49 Seeking Alpha
   Strata Skin Sciences Consensus Indicates Potential 166.7% Upside  2021/06/23 12:06:15 DirectorsTalk
Strata Skin Sciences found using ticker (SSKN) now have 3 analysts covering the stock. The analyst consensus points to a rating of ''Strong_Buy''. The target price ranges between 5 and 3 calculating the mean target price we have 3.92. Given that the stocks previous close was at 1.47 this is indicating there is a potential upside of 166.7%. The day 50 moving average is 1.51 and the 200 moving average now moves to 1.39. The market cap for the company is $47m. You can visit the company''s website by visiting: /> [stock_market_widget type="chart" symbol="SSKN" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] STRATA Skin Sciences, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others.
   Here is What Hedge Funds Think About Strata Skin Sciences, Inc. (SSKN)  2021/06/14 20:00:27 Insider Monkey
   STRATA Skin Sciences to Participate in the Oppenheimer MedTech, Tools & Diagnostics Summit  2021/05/18 12:00:00 GlobeNewswire
HORSHAM, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming Oppenheimer MedTech, Tools & Diagnostics Summit.
   Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Flexion Therapeutics (FLXN) and MedMen Enterprises (OtherMMNFF)  2021/05/13 11:20:21 Smarter Analyst
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Strata Skin Sciences (SSKN), Flexion Therapeutics The post Analysts Offer Insights on Healthcare Companies: Strata Skin Sciences (SSKN), Flexion Therapeutics (FLXN) and MedMen Enterprises (OtherMMNFF) appeared first on Smarter Analyst .
   Analysts Are Bullish on These Healthcare Stocks: Strata Skin Sciences (SSKN), Acceleron Pharma (XLRN)  2021/05/13 10:15:39 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Strata Skin Sciences (SSKN), Acceleron The post Analysts Are Bullish on These Healthcare Stocks: Strata Skin Sciences (SSKN), Acceleron Pharma (XLRN) appeared first on Smarter Analyst .

calendar